Murcia, Spain

Enrique Aguado Vidal

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrique Aguado Vidal. Retrieved from https://idiyas.com/inventor/enrique-aguado-vidal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Enrique Aguado Vidal

Introduction

Enrique Aguado Vidal is a notable inventor based in Murcia, Spain. He has made significant contributions to the field of biotechnology, particularly in the area of genetic research. His work focuses on the development of innovative solutions for medical applications.

Latest Patents

One of his key patents is titled "Mutated gene coding for a lat protein and the biological applications thereof." This invention relates to a mutated gene coding for a mutant LAT protein that leads to exaggerated T2 differentiation. The patent encompasses biological structures containing the mutant, including non-human LAT gene, mutated animals, plasmids, chromosomal DNAs, and embryos comprising the mutated gene. Additionally, it outlines screening methods for drugs useful in treating asthma and allergies, as well as methods for producing IgE antibodies.

Career Highlights

Enrique Aguado Vidal is affiliated with the National Institute of Health and Medical Research, where he conducts his research and development activities. His work has garnered attention for its potential impact on therapeutic strategies for allergic conditions.

Collaborations

He has collaborated with notable colleagues, including Marie Malissen and Bernard Malissen, contributing to advancements in their shared field of research.

Conclusion

Enrique Aguado Vidal's innovative work in genetic research and his patent on the mutated LAT protein exemplify his commitment to advancing medical science. His contributions hold promise for future treatments in allergy and asthma management.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…